Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Artichoke and Reduced Low-Density Lipoprotein Level

Research synthesisHigh evidenceMixed effect size5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies, all reported beneficial effects of artichoke on reducing low-density lipoprotein (LDL) cholesterol, with statistically significant findings in every case. Effect sizes were mixed (small to moderate), and the most-studied dose was 600 mg daily of artichoke leaf extract. Effects were typically observed at 6–8 weeks (median study duration 51 days), primarily in clinical populations with non-alcoholic fatty liver disease (NAFLD) or undergoing bariatric surgery.

  • Effective dose range: 600 mg daily
  • Studied populations: people with non-alcoholic fatty liver disease (NAFLD), bariatric surgery candidates

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Most studies focused on clinical populations with NAFLD or metabolic conditions, so benefits may not generalize to healthy adults. Study durations were relatively short (42–60 days), and long-term efficacy remains unclear.

Generated Jun 15, 2026
Doses used in studies
  • mg/day: 600 (median 600, IQR 600600) 1 study
Time to effect
Median: 7.3 weeks · IQR 6.6 weeks7.9 weeks · Range 6 weeks8.6 weeks — Reported in 2 of 5 studies
Safety in these studies
5 of 5 papers
Back to top